INTERVIEW: Zeus Capital – The new age of live-biotherapeutics
The new age of live-biotherapeutics is the topic of conversation when Dr Gary Waanders, Healthcare Research Director at Zeus Capital talks to DirectorsTalk. Gary explains what is driving the interest